What are the risks of sun exposure for patients taking Olmesartan-HCTZ (olmesartan-hydrochlorothiazide)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board

Educational purpose only • Exercise caution as content is pending human review

Article Review Status

Submitted

Under Review

Approved

Last updated: June 11, 2025 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Patients taking Olmesartan-HCTZ should be cautious about sun exposure due to the increased risk of photosensitivity reactions associated with the hydrochlorothiazide (HCTZ) component, as reported in a 2022 study published in Nature Reviews Cardiology 1. The hydrochlorothiazide (HCTZ) component of Olmesartan-HCTZ can trigger a variety of photosensitive eruptions, including an exaggerated sunburn reaction, dermatitis, and a lichenoid eruption, as noted in the study 1. These reactions can occur within minutes to hours after sun exposure and may present as:

Exaggerated sunburn
Skin rash
Itching
Hives To minimize these risks, patients should:
Wear protective clothing
Apply broad-spectrum sunscreen with SPF 30 or higher
Wear sunglasses
Limit sun exposure, especially between 10 AM and 4 PM when UV rays are strongest
Seek shade when outside, particularly around midday
Keep in mind that radiation can be stronger when reflected by water, sand, or snow It is essential for patients to be aware of these potential risks and take necessary precautions to protect themselves from excessive sun exposure, as advised in the study 1.

From the Research

Risks of Sun Exposure for Patients Taking Olmesartan-HCTZ

There are no direct studies that assess the risks of sun exposure for patients taking Olmesartan-HCTZ 2, 3, 4, 5, 6.
However, it is known that hydrochlorothiazide (HCTZ), a component of Olmesartan-HCTZ, can increase the risk of sun-induced skin reactions, such as photosensitivity and sunburn 5.
Patients taking Olmesartan-HCTZ should exercise caution when exposed to sunlight and take protective measures, such as wearing protective clothing and using sunscreen, to minimize the risk of sun-induced skin reactions.
The studies available focus on the efficacy and safety of Olmesartan-HCTZ in treating hypertension, but do not provide specific information on the risks of sun exposure 2, 3, 4, 5, 6.
Further research is needed to fully understand the risks of sun exposure for patients taking Olmesartan-HCTZ.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Clinical efficacy and safety of olmesartan/hydrochlorothiazide combination therapy in patients with essential hypertension.

Vascular health and risk management, 2008

Research

Effectiveness of the fixed-dose combination of olmesartan/amlodipine/hydrochlorothiazide for the treatment of hypertension in patients stratified by age, race and diabetes, CKD and chronic CVD.

Expert review of cardiovascular therapy, 2013

Research

Efficacy and safety of a stepped-care regimen using olmesartan medoxomil, amlodipine and hydrochlorothiazide in patients with moderate-to-severe hypertension: an open-label, long-term study.

Clinical drug investigation, 2009

Research

Adding hydrochlorothiazide to olmesartan dose dependently improves 24-h blood pressure and response rates in mild-to-moderate hypertension.

Journal of hypertension, 2005

Research

Combination therapy with olmesartan medoxomil and hydrochlorothiazide: secondary analysis of the proportion of patients achieving recommended blood pressure goals from a randomized, double-blind, factorial study.

American journal of cardiovascular drugs : drugs, devices, and other interventions, 2009

Related Questions

What is the management plan for a patient with stage 2 hypertension on Cardizem (Diltiazem) 180mg daily and Olmesartan Medoxomil/Hydrochlorothiazide 40mg-12.5mg tablet daily?

What is the olmesartan dose equivalent to lisinopril 20mg?

What is the next best addition for a patient with uncontrolled hypertension on amlodipine (calcium channel blocker) and olmesartan (angiotensin II receptor blocker) 10/40?

Can hidralazine and olmesartan be used together?

Is a blood pressure of 106/80 mmHg adequately managed with olmesartan 20 mg and hydrochlorothiazide 12.5 mg in a patient post-stroke?

What should be done if a patient has Right Bundle Branch Block (RBBB) and Left Anterior Fascicular Block (LAFB) of unknown duration?

What are the treatment options for a herniated disc?

What are the discharge instructions for managing viral illnesses?

How do I treat mild type 2A von Willebrand disease?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question